These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 12500480)

  • 21. Spinning the wheel on ImClone.
    Varchaver N
    Fortune; 2003 Apr; 147(8):123-5. PubMed ID: 12728651
    [No Abstract]   [Full Text] [Related]  

  • 22. Consolidation in 2002 a serious case of déjà vu.
    Goedert J
    Health Data Manag; 2003 Jan; 11(1):54-6,59. PubMed ID: 12561738
    [No Abstract]   [Full Text] [Related]  

  • 23. Bugs or drugs, tortoises or hares?
    Jacobs T
    Nat Biotechnol; 2005 Mar; 23(3):293. PubMed ID: 15765079
    [No Abstract]   [Full Text] [Related]  

  • 24. American Home bids $8.5 billion to buy New Jersey drug company.
    Scott L
    Mod Healthc; 1994 Aug; 24(32):12. PubMed ID: 10135368
    [No Abstract]   [Full Text] [Related]  

  • 25. The stampede to convertibles.
    Jacobs T
    Nat Biotechnol; 2003 Aug; 21(8):855. PubMed ID: 12894195
    [No Abstract]   [Full Text] [Related]  

  • 26. A change in the market--investing in diagnostics.
    Batchelder K; Miller P
    Nat Biotechnol; 2006 Aug; 24(8):922-6. PubMed ID: 16900131
    [No Abstract]   [Full Text] [Related]  

  • 27. Japanese giants renew interest in industrial biotech.
    Sipp D
    Nat Biotechnol; 2005 Mar; 23(3):275-6. PubMed ID: 15765071
    [No Abstract]   [Full Text] [Related]  

  • 28. AHP's awful losing streak.
    Whitford D
    Fortune; 1999 Nov; 140(10):52, 56. PubMed ID: 10662389
    [No Abstract]   [Full Text] [Related]  

  • 29. Hidden in plain view.
    Jacobs T
    Nat Biotechnol; 2003 Jun; 21(6):603. PubMed ID: 12776141
    [No Abstract]   [Full Text] [Related]  

  • 30. When your stock takes a nosedive.
    Jacobs T
    Nat Biotechnol; 2006 Feb; 24(2):144. PubMed ID: 16465152
    [No Abstract]   [Full Text] [Related]  

  • 31. Boom vs. bust.
    Serb C
    Hosp Health Netw; 1999 Mar; 73(3):58-9, 2. PubMed ID: 10191735
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Biotech parks proliferate, despite concerns over sustainability.
    Jia H; Jayaraman KS; Orellana C
    Nat Biotechnol; 2003 Nov; 21(11):1259-60. PubMed ID: 14595344
    [No Abstract]   [Full Text] [Related]  

  • 33. Fortune 1,000. Ranked within industries. 8. Chemicals.
    Fortune; 2004 Apr; 149(7):F46. PubMed ID: 15077536
    [No Abstract]   [Full Text] [Related]  

  • 34. Fortune 1,000 ranked within industries. 48. Pharmaceuticals.
    Fortune; 2004 Apr; 149(7):F59-F60. PubMed ID: 15077541
    [No Abstract]   [Full Text] [Related]  

  • 35. The perfect mix for your portfolio.
    Simons J
    Fortune; 2003 Dec; 148(13):134-8. PubMed ID: 14712541
    [No Abstract]   [Full Text] [Related]  

  • 36. When less is more.
    Booth BL
    Nat Biotechnol; 2007 Aug; 25(8):853-7. PubMed ID: 17687357
    [No Abstract]   [Full Text] [Related]  

  • 37. Early-stage returns?
    Booth BL
    Nat Biotechnol; 2006 Nov; 24(11):1335-40. PubMed ID: 17093473
    [TBL] [Abstract][Full Text] [Related]  

  • 38. OTA report assails profits on new drugs.
    Wagner L; Weissenstein E
    Mod Healthc; 1993 Mar; 23(9):3. PubMed ID: 10124249
    [No Abstract]   [Full Text] [Related]  

  • 39. The outlook for 22 industries.
    Aley J; Brown JY; McGowan J; Woods W
    Fortune; 1994 Jan; 129(1):48-52, 56. PubMed ID: 10131031
    [No Abstract]   [Full Text] [Related]  

  • 40. Commercializing nanotechnology.
    Mazzola L
    Nat Biotechnol; 2003 Oct; 21(10):1137-43. PubMed ID: 14520392
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.